Top 3 Health Care Stocks That May Explode In September

Core Insights - The health care sector has identified oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for assessing stock performance, with an RSI below 30 indicating oversold conditions [1] Company Summaries - Boston Scientific Corp (BSX): Upgraded from Perform to Outperform by Oppenheimer analyst Steven Lichtman, with a price target raised from $118 to $125. The stock has fallen approximately 5% in the past five days, with a 52-week low of $80.64. Current RSI is 27.3, and shares closed at $98.23 [7] - aTyr Pharma Inc (ATYR): Announced that its Phase 3 EFZO-FIT study did not meet its primary endpoint, leading to a stock decline of around 80% over the past five days, with a 52-week low of $0.97. Current RSI is 22.6, and shares closed at $1.05 [7] - Reviva Pharmaceuticals Holdings Inc (RVPH): Recently priced a $9 million public offering, resulting in a stock decline of approximately 21% over the past month, with a 52-week low of $0.30. Current RSI is 24.5, and shares closed at $0.42 [7]